Edesa Biotech Inc (EDSA)
2.10
-0.10
(-4.55%)
USD |
NASDAQ |
Nov 15, 16:00
2.49
+0.39
(+18.57%)
After-Hours: 20:00
Edesa Biotech Free Cash Flow (Quarterly): -0.8565M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.8565M |
| March 31, 2024 | -1.660M |
| December 31, 2023 | -1.406M |
| September 30, 2023 | -1.468M |
| June 30, 2023 | -1.805M |
| March 31, 2023 | -1.572M |
| December 31, 2022 | -1.791M |
| September 30, 2022 | -5.628M |
| June 30, 2022 | -3.028M |
| March 31, 2022 | -0.4179M |
| December 31, 2021 | -3.211M |
| September 30, 2021 | -0.3539M |
| June 30, 2021 | -3.123M |
| March 31, 2021 | -7.182M |
| December 31, 2020 | -3.012M |
| September 30, 2020 | -1.677M |
| June 30, 2020 | -1.383M |
| March 31, 2020 | -1.171M |
| December 31, 2019 | -0.7897M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -1.287M |
| December 31, 2018 | -1.314M |
| September 30, 2018 | -0.9926M |
| June 30, 2018 | -1.267M |
| Date | Value |
|---|---|
| March 31, 2018 | -1.560M |
| December 31, 2017 | -1.179M |
| September 30, 2017 | -1.220M |
| June 30, 2017 | -1.015M |
| March 31, 2017 | -1.319M |
| December 31, 2016 | -1.450M |
| September 30, 2016 | -1.299M |
| June 30, 2016 | -1.098M |
| March 31, 2016 | -1.161M |
| December 31, 2015 | -1.350M |
| September 30, 2015 | -0.9867M |
| June 30, 2015 | -1.061M |
| March 31, 2015 | -1.315M |
| December 31, 2014 | -1.324M |
| August 31, 2014 | -0.8166M |
| May 31, 2014 | -1.069M |
| February 28, 2014 | -1.460M |
| November 30, 2013 | -1.20M |
| August 31, 2013 | -0.5659M |
| May 31, 2013 | -0.7262M |
| February 28, 2013 | -0.7888M |
| November 30, 2012 | -0.7245M |
| August 31, 2012 | -0.9767M |
| May 31, 2012 | -1.019M |
| February 29, 2012 | -1.131M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-7.182M
Minimum
Mar 2021
-0.3539M
Maximum
Sep 2021
-2.186M
Average
-1.660M
Median
Mar 2024
Free Cash Flow (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 16.90M |
| Lexaria Bioscience Corp | -1.288M |
| Xenon Pharmaceuticals Inc | -34.19M |
| ESSA Pharma Inc | -5.745M |
| ImmunoPrecise Antibodies Ltd | -1.524M |